ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1125

Study Variation in Estimating GFR from Creatinine, Cystatin C, Age, and Sex

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Author

  • Fino, Nora F., University of Utah Health, Salt Lake City, Utah, United States

Group or Team Name

  • Chronic Kidney Disease Epidemiology Collaboration.
Background

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations estimate GFR using serum creatinine and/or cystatin C, age, and sex. These equations were created by pooling datasets from multiple research studies and populations into a single dataset. We investigate implications of study variation on the relationship of GFR with its predictor variables in CKD-EPI datasets.

Methods

We combined data used to develop and validate the 2021 CKD-EPI equations (11,737 individuals in 23 studies). For GFR equations based on creatinine or cystatin C, random effects modeling was used to partition measured GFR (mGFR) into five components: the average predictor-GFR relationship across studies, predictable variation due to differences in studies of CKD populations vs. non-CKD populations, non-predictable variation across studies, within-study prediction errors, and measurement error.

Results

Overall, the average predictor-GFR relationship across studies did not substantially differ from the pooled 2021 CKD-EPI equations, which yield estimates intermediate between CKD and non-CKD populations. Still, considerable variation persisted beyond differences by CKD population (Figure). For lower creatinine/cystatin C levels, 50-70% of the GFR estimation error can be attributed to between-study differences, whereas 30-50% of the error is due to estimating GFR from predictor variables within a given study, after accounting for mGFR measurement error. For higher levels, 15-37% is due to between-study differences and 63-85% is due to within-study errors.

Conclusion

Our results largely corroborate the CKD-EPI equations, which remain a pragmatic solution for widespread GFR estimation. Single study GFR equations may underestimate external prediction error by ignoring study level variability, especially in non-CKD populations.

Forest plot of CKD-EPI equation coefficients and population-averaged and study-specific coefficients from the random effects models for creatinine and cystatin C.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)